Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-29

Clinical Trial Update: Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe [NA]

View source ↗

Summary

A completed clinical trial comparing high-dose simvastatin alone to combination therapy with ezetimibe, examining effects on NF-κB activity in Type 2 diabetes a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Heidelberg University | Conditions: Type 2 Diabetes, Inflammation | NA | Status: COMPLETED